Yip et al. [18] showed that the levels of circulating EPCs (CD31+/CD34+, CD62E+/CD34+) and (KDR+/CD34+) were significantly higher among patients with AIS than in the at-risk control subjects. This evidence concerns the gene SELE and androgen insensitivity syndrome.